A process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide of the formula (Ia),
- comprising steps (i), (iii), (v) and (vi):
- (i) resolving by optical resolution racemic 2-cyanoethyl-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate of the formula (IV)
- with a chiral substituted tartaric ester of the formula (IIIa) or (IIIb)
- to obtain one or more of the diastereomeric salts
- where Ar is unsubstituted or substituted aryl or heteroaryl,
- (iii) converting the diastereomeric salt obtained in step (i) to the compound of formula (IVa)
- (v) hydrolysing the compound of formula (IVa) with sodium hydroxide solution in a THF/water mixture (2:1) to give the compound of the formula (VIIa)
- (vi) reacting the compound of the formula (VIIa), in THF as solvent, firstly with 1,1-carbodiimidazole and catalytic amounts of 4-(dimethylamino)pyridine, adding hexamethyldisilazane and then heating the mixture under reflux for 16-24 hours, and then adding a THF/water mixture, so as to obtain the compound of formula (Ia).